You have 9 free searches left this month | to do more

busulfan

Busulfan is a drug used to treat Leukemia, Lymphoma, Myelodysplastic Syndromes, and other conditions. Busulfan is being actively studied in 104 studies and prior, has been studied in 177.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterFred Hutchinson Cancer Research CenterIvan S Moiseev
Fred Hutchinson Cancer Research CenterUniversity of Texas MD Anderson Cancer CenterRichard Maziarz
Masonic Cancer Center, University of MinnesotaM D Anderson Cancer CenterCaridad Martinez
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Acute Leukemia
  • Busulfan
  • Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
2021-05-19
May 19, 2021
M
Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-01-12
Jan 12, 2021
S
Recruiting
  • Leukemia, Acute Lymphoblastic
  • +5 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
2021-06-21
Jun 21, 2021
M
Terminated
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
2021-03-17
Mar 17, 2021
A
Withdrawn
  • Refractory Brain Tumors
  • Busulfan
  • (no location specified)
2020-08-03
Aug 3, 2020
N
Recruiting
  • Chronic Granulomatous Disease
  • Busulfan
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-06-18
Jun 18, 2021
T
Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Busulfan
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
2021-03-08
Mar 8, 2021
M
Completed
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-12-16
Dec 16, 2020
M
Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-10-02
Oct 2, 2020
M
Completed
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-04-23
Apr 23, 2020
C
Completed
  • Acute Myeloid Leukemia
  • +10 more
  • total marrow irradiation
  • +7 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
2021-05-05
May 5, 2021
M
Completed
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
2020-09-22
Sep 22, 2020
K
Recruiting
  • T-cell Non-Hodgkin Lymphoma
  • Lymphoma, Extranodal NK-T-Cell
  • Busan, Korea, Republic of
  • +1 more
2020-09-07
Sep 7, 2020
D
Active, not recruiting
  • Leukemia, Lymphoid
  • +6 more
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
2021-01-29
Jan 29, 2021
M
Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2019-12-13
Dec 13, 2019
C
Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • busulfan
  • +7 more
  • (no location specified)
2021-02-15
Feb 15, 2021
U
Terminated
  • Myeloid Malignancy
  • +5 more
  • San Francisco, California
    University of California, San Francisco
2020-02-25
Feb 25, 2020
U
Active, not recruiting
  • Multiple Myeloma
  • Busulfan
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
2021-10-07
Oct 7, 2021
S
Recruiting
  • Genetic Rare Disease
  • Busulfan
  • Seoul, Daehangno, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
2021-03-28
Mar 28, 2021
J
Recruiting
  • Acute Myeloid Leukemia (AML)
  • +4 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-07-08
Jul 8, 2021
N
Not yet recruiting
  • Immunodeficiency
  • Hematopoietic Stem Cell Transplantation
  • Post-Transplant Cyclophosphamide (PTCY)
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-10-14
Oct 14, 2021
S
Recruiting
  • Acute Lymphoblastic Leukemia
  • Busulfan
  • Seoul, Daehangno, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
2021-06-15
Jun 15, 2021
N
Recruiting
  • Lymphoproliferative Disorders
  • +4 more
  • Busulfan test dose
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-09-02
Sep 2, 2021
M
Recruiting
  • Hematologic Disorders
  • +2 more
  • Busulfan
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
2021-07-12
Jul 12, 2021